Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

Selective chemical epilation effectively treats tinea capitis without harmful side effects.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

Curcuma aeruginosa rhizome extracts show potential as anticancer agents, with varying effectiveness against breast cancer cells.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

M50054 may help treat hepatitis and hair loss from chemotherapy.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Topical putrescine and spermine increased DNA synthesis in hairless mouse skin.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.